Autoantibody Reduction for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Clinical trial NCT03286556 · COMPLETED

Trial details

NCT number: NCT03286556
Sponsor: University of Alabama at Birmingham
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis, Acute Fatal Form

Start date: 2018-09-04
Primary completion: 2024-08-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.